Nirmatrelvir-ritonavir effectively lowers hospitalization rates and long COVID symptoms in non-hospitalized, high-risk patients with mild to moderate COVID-19.

In the medicine and endocrinology department of the Mali Hospital in Bamako, foot problems accounted for 16.37% of hospitalized diabetics, including 40.4% amputations and 5.8% deaths [ 3 ]. In Mali, ...